Want to join the conversation?
Life science research company $ILMN posted 1Q16 GAAP net income attributable to Illumina stockholders of $90MM or $0.60 per diluted share compared to $137MM or $0.92 per diluted share in 1Q15. Revenue of $572MM increased 6% compared to $539MM in 1Q15. Non-GAAP net income attributable to Illumina stockholders was $106MM or $0.71 per diluted share.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.